Trinity Biotech (TRIB) Revenue (2016 - 2025)
Historic Revenue for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to -$2.1 million.
- Trinity Biotech's Revenue fell 11299.63% to -$2.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.1 million, marking a year-over-year decrease of 10351.05%. This contributed to the annual value of $61.6 million for FY2024, which is 831.05% up from last year.
- As of Q2 2025, Trinity Biotech's Revenue stood at -$2.1 million, which was down 11299.63% from $15.9 million recorded in Q4 2024.
- Trinity Biotech's 5-year Revenue high stood at $25.8 million for Q2 2021, and its period low was -$2.1 million during Q2 2025.
- In the last 5 years, Trinity Biotech's Revenue had a median value of $15.7 million in 2022 and averaged $16.0 million.
- Its Revenue has fluctuated over the past 5 years, first surged by 6127.68% in 2021, then tumbled by 11299.63% in 2025.
- Quarter analysis of 5 years shows Trinity Biotech's Revenue stood at $19.5 million in 2021, then fell by 19.46% to $15.7 million in 2022, then decreased by 14.61% to $13.4 million in 2023, then rose by 18.09% to $15.9 million in 2024, then tumbled by 112.98% to -$2.1 million in 2025.
- Its Revenue was -$2.1 million in Q2 2025, compared to $15.9 million in Q4 2024 and $15.2 million in Q3 2024.